Advancing the global public health agenda for NAFLD: a consensus statement
Open accessThe DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics — from epidemiology, awareness, care and treatment to public health policies and leadership — that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD. Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease with a substantial burden worldwide. In this Consensus Statement, a global multidisciplinary group of experts develop consensus statements and recommendations addressing a broad range of topics on NAFLD to raise awareness and spur action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Self-citationChalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Self-citationGlobal Burden of Disease Cancer Collaboration, Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., Dicker, D. J., Chimed-Orchir, O., Dandona, R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,215
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Self-citationEASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citation2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Self-citationExpanding consensus in portal hypertension
de Franchis, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.022 · Cited by 3,078
Research works printed but not linked: 2
- Lazarus, J. V. et al. The global non-alcoholic fatty liver disease (NAFLD) preparedness index: are countries ready to tackle the challenge? Int. Liver Congr. 75 (Suppl. 2), 23–26 (2021).
- Grime, M. M. & Wright, G. in Wiley StatsRef: Statistics Reference Online 1–6 (Wiley, 2011).
Cited by
Items 501–600 of 807
Zeng, T., Li, F., Yang, M. J., Wu, Y., Cui, W., Mou, H., & Luo, X. (2025) · Biomedicines · doi:10.3390/biomedicines13020425 · Cited by 4
“MASLD represents a spectrum of liver pathology, ranging from asymptomatic steatosis to more severe conditions, such as steatohepatitis, fibrosis, cirrhosis, and even hepatocellular carcinoma [11,12].”
Combined Cold Exposure and Exercise Improves NAFLD: Mechanistic Insights
GENG, X., Rao, Z., ZHANG, J., Huang, P., Qu, C., Wu, D., Wei, Q., Liu, S., Zhuang, X., & Zhao, J. (2025) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003719 · Cited by 4
Keklikkıran, Ç., Stepanova, M., Younossi, Z. M., & Yilmaz, Y. N. (2023) · Digestive Diseases · doi:10.1159/000531981 · Cited by 4
“…fatty liver disease (NAFLD) – which is de fi ned by the presence of steatosis in > 5% of hepatocytes in the absence of signi fi cant alcohol consumption or alternative etiologies that cause hepatic fat accumulation – affects approximately one-quarter of the global adult population [1 – 3].”
BackgroundSelf-citationNon-alcoholic Fatty Liver in Children and Adolescents in Saudi Arabia
Mujlli, G., Mahzari, M. M., Alslamah, I., Syed, J., Omair, A. A., Abulmeaty, M., & Aldisi, D. A. (2023) · Cureus · doi:10.7759/cureus.46380 · Cited by 4
Behari, J., Bradley, A., Townsend, K., Becich, M. J., Cappella, N., Chuang, C. H., Fernández, S., Ford, D. E., Kirchner, H. L., Morgan, R. H., et al. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08186-8 · Cited by 4
Livzan, M. A., Lyalyukova, E. A., Друк, И. В., Safronova, S. S., Аскерович, Х. А., Martirosian, K. A., Petrosian, V. Y., & Galakhov, Y. S. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-218-10-5-47 · Cited by 4
Ni, W., Lu, Y., & Wang, W. (2024) · Medicine · doi:10.1097/md.0000000000038008 · Cited by 4
“[41] The LDSC genetic correlation analysis revealed a significant genetic correlation between T2DM and NAFLD.”
BackgroundJankowska, I., Socha, P., Gliwicz, D., Lipiński, P., Rokicki, D., Kaliciński, P., Danielewska, E., & Grenda, R. (2024) · Pediatric Transplantation · doi:10.1111/petr.14825 · Cited by 4
Self-citationAnastasaki, M., Papadakis, S., Gergianaki, I., Papastamatiou, L., Aligizakis, E., Grillaki, N., Boutzoukaki, E., Nektarios, S., Anastasiou, F., Mendive, J. M., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1383112 · Cited by 6
Self-citationDoustmohammadian, A., Zamani, F., Hébert, J. R., Moradi‐Lakeh, M., Esfandyiari, S., Amirkalali, B., Motamed, N., Maadi, M., Price, S., Gholizadeh, E., et al. (2024) · Journal of Health Population and Nutrition · doi:10.1186/s41043-024-00721-1 · Cited by 4
“…other highly prevalent non-communicable diseases (NCDs), including type 2 diabetes mellitus, metabolic syndrome, and cardiovascular diseases [4, 5], with a great deal of overlap in the public health and healthcare system strategies required for managing and preventing these health conditions [6].”
Huang, Z., Zhang, S.-B., Xu, S., Gu, X.-N., Wu, Z., Zhang, Y., Li, J., & Ji, L.-L. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01568-w · Cited by 4
“In severe cases, NASH might become worsen and further progress into liver fi brosis, eventually leading to cirrhosis, liver failure and even hepatocellular carcinoma (HCC) [5].”
Hidden Hunger: A Forgotten Comorbidity of Metabolic‐Syndrome‐Associated Fatty Liver Disease
Agu, P. C., & Lu, J. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70134 · Cited by 6
Romero, C. L., Liang, J., Fernández-Lizaranzu, I., Herrojo, J. A., Castell, J., Alba, C. D. P., Pascual, I. D., & Romero‐Gómez, M. (2022) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2022.8777/2022 · Cited by 8
Self-citationLing, Y., Li, Y., & Li, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01111-x · Cited by 4
RESISTIN GENE POLYMORPHISM AND NONALCOHOLIC FATTY LIVER DISEASE RISK
Tabaeian, S. P., Mahmoudi, T., Rezamand, G., Nobakht, H., Dabiri, R., Farahani, H., Asadi, A., & Zali, M. R. (2022) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202204000-86 · Cited by 4
A Varying Coefficient Model to Jointly Test Genetic and Gene–Environment Interaction Effects
Zhou, Z., Ku, H., Manning, S. E., Zhang, M., & Xing, C. (2023) · Behavior Genetics · doi:10.1007/s10519-022-10131-w · Cited by 4
“NAFLD is the most common chronic liver disease worldwide affecting approximately 25% of the global adult population, and its prevalence has increased over the last 20 years, paralleling the increase in obesity, its major risk factor (Younossi et al. 2019; Lazarus et al. 2021).”
BackgroundSociosanitary Legal and Economic Aspects in Nursing Homes for the Elderly in Spain
Vilaplana‐Prieto, C., Martínez, C. S. G., Pérez, P. E., & Legáz, I. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20064928 · Cited by 4
“The residential models in Spain are mainly oriented towards offering social and health services to the elderly, in which health professionals establish what is best for them according to their needs [7,8].”
BackgroundHadjihambi, A., Velliou, R.-I., Tsialios, P., Legaki, A., Chatzigeorgiou, A., & Rouchota, M. G. (2023) · Journal of Visualized Experiments · doi:10.3791/64838 · Cited by 4
Li, W., Spray, B. J., Børsheim, E., Korourian, S., & Hakkak, R. (2023) · Journal of Medicinal Food · doi:10.1089/jmf.2023.0118 · Cited by 4
Forlano, R., Stanic, T., Jayawardana, S., Mullish, B. H., Yee, M. S., Mossialos, E. A., Goldin, R. D., Petta, S., Tsochatzis, E. A., Thursz, M. R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2135338/v1 · Cited by 4
Self-citationNon-Alcoholic Fatty Liver Disease in Everyday Clinical Practice: From Diagnosis to Therapy
Kosmalski, M., & Mokros, Ł. (2025) · Life · doi:10.3390/life15030363 · Cited by 4
“…diabetologists, endocrinologists, hepatologists, bariatric surgeons, cardiologists, nephrologists, oncologists, psychiatrists, psychologists, gynecologists, pedia-tricians, and geneticists), as well as governmental and non-governmental institutions, both at the local and international level [1,2].”
Torabi, S., Mohammadi, Y., Hoseini, M.-S., Rezaei, A., Mohammadi, A., & Bahreini, E. (2025) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2025.09.002 · Cited by 3
Rong, F., Mai, Y., Shou, L., Zhu, X., Li, M., Zhu, L., Sun, X., & Zhao, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1502671 · Cited by 3
Zhu, Q., Li, Z., Cai, C., & Li, D. (2025) · Discover Oncology · doi:10.1007/s12672-025-03276-7 · Cited by 3
“Compared to other liver diseases, MAFLD, which consists of diabetes, obesity, and hypertension, causes even higher healthcare expenses [5–7].”
Fawzy, M. M., Khan, K. S., CHIEN, P. F. W., Bueno‐Cavanillas, A., Martín‐Díaz, M., Zamora, J., Ruano‐Raviña, A., Pacey, A. A., Zhang, J. J., Khalaf, Y., et al. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70374 · Cited by 4
“35,36 For the merged responses “strongly agree” and “agree” we categorized the superma-jority agreement for the statements as follows: grade U (unanimous) defined as 100% agreement, grade A (near-unanimous defined as 90%–99% agreement), grade B (strong agreement defined as 78%– 89% agreement), and…”
Jiao, L., Yang, Y., Huang, Y., Shang, H., Liu, Z., Li, W., Sun, J., Yang, H., Hu, J., & Wan, Y. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c07061 · Cited by 3
Xiao, Z., Li, X., Gong, J., & Zhou, F. (2025) · European journal of medical research · doi:10.1186/s40001-025-03445-y · Cited by 3
“NAFLD is currently recognized as a global public health challenge [15].”
Lee, C.-W. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i12.113844 · Cited by 3
Wan, K. S., Rifin, H. M., Yusoff, M. F. M., Chan, W., Ratnam, K. K. Y., Ganapathy, S. S., Hamid, H. A. A., Mohamad, M. M., Noor, N. M., Mustapha, F. I., et al. (2026) · Scientific Reports · doi:10.1038/s41598-025-31737-0 · Cited by 3
“This aligns with the movement to advance the public health agenda on MAFLD at the global, regional, and national levels 3 .”
InfluentialSelf-citationZhang, C., Luo, Y., Xiong, Y., Chen, L., Zhao, H., Qiu, Z., & Yang, Y. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c09366 · Cited by 3
Mohamadi, B., Ostadan, M. T., Shokri, S., Bakhtiyari, A., Rasooli, R., Sadighara, P., & Bekheir, S. A. (2026) · Toxicology Reports · doi:10.1016/j.toxrep.2026.102216 · Cited by 6
“Therefore, NAFLD is one of the most common liver-related diseases in the world [4].”
Wang, Q., Guo, J., Liu, S., Cao, X., Guo, Z., Rui, L., Zheng, L., & Wang, C. (2026) · PLoS ONE · doi:10.1371/journal.pone.0342697 · Cited by 3
“By 2050, the global population aged ≥60 years will double [9], with low/middle-income countries experiencing the most rapid aging.”
Wang, H., Wu, X., Mou, Y., Wang, Q., Wu, X., Rao, Q., Shi, Y., Liu, X., Zheng, X., Yuan, C., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121677 · Cited by 3
Wan, X., Liu, X., Meng, D., Wang, A., Song, X., Huang, Y., Zhang, F., Lin, X., Yao, J., Zheng, Y., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.04.059 · Cited by 4
Liver disease diagnostics and access barriers in African settings: a narrative review
Jagunmolu, H. A., Oyetola, E. O., Lawal, Y. A., Akinsanya, S. O., Ibrahim, M. A., Idowu, T. O., Oyelude, S. O., Jubreel, M., Ajibade, D., Oyetola, O. T., et al. (2026) · Journal of Clinical Pathology · doi:10.1136/jcp-2026-210662 · Cited by 3
Zhou, X., Jeong, S., Chen, Q., Targher, G., Byrne, C. D., Chew, N. W., Younossi, Z. M., Lip, G. Y. H., Tilg, H., George, J., et al. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01255-z · Cited by 4
Self-citationSharkawy, S. I. E., Aboul-Enien, Y. H., Elnagar, B., Elkhalawany, W. A., & Badawi, R. (2024) · The Egyptian Heart Journal · doi:10.1186/s43044-024-00462-w · Cited by 3
Hao, X., He, H., Tao, L., Zhao, W., & Wang, P. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03229-4 · Cited by 34
“The prevalence of MAFLD continues to increase in tandem with global obesity rates [2], and MAFLD has become the world’s most common chronic liver disease [3].”
BackgroundLee, J., Amatya, R., Kim, K. E., Park, Y.-H., Hong, E., Djayanti, K., Min, K. A., Roh, G. S., & Shin, M. C. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.061 · Cited by 3
Nouri, S., Navari, M., Shafiee, R., Mahmoudi, T., Rezamand, G., Asadi, A., Nobakht, H., Dabiri, R., Farahani, H., & Tabaeian, S. P. (2024) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20231537 · Cited by 3
Forlano, R., Stanic, T., Jayawardana, S., Mullish, B. H., Yee, M. S., Mossialos, E. A., Goldin, R. D., Petta, S., Tsochatzis, E. A., Thursz, M. R., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307500 · Cited by 4
Self-citationFu, W., Cheng, G.-B., Zhao, J., Lv, L.-Y., & Ding, Y. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i2.97741 · Cited by 3
Association between aspirin use and the risk of incident nonalcoholic fatty liver disease
Huang, H., Liu, Z., & Xu, C. (2025) · European Journal of Epidemiology · doi:10.1007/s10654-025-01224-x · Cited by 3
“NAFLD is benign for most patients but may progress to end-stage liver disease [27].”
Hancock, M., Beyer, C., Fuchs, M., Harisinghani, M. G., Jalal, P. K., Ndaa, M., Samala, N. R., Vargas, J. D., & Jayaswal, A. N. A. (2025) · Journal of Medical Economics · doi:10.1080/13696998.2025.2550113 · Cited by 3
“The lifetime cost associated with all US patients with MASH is estimated at $222.6 billion 9,10 .”
InfluentialSelf-citationCroatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
Jukić, L. V., Grgurević, I., Mikolašević, I., Kanižaj, T. F., Milić, S., Mrzljak, A., Premužić, M., Hrstić, I., Knežević-Štromar, I., Ljubičić, N., et al. (2021) · Acta Clinica Croatica · doi:10.20471/acc.2021.60.s1.03 · Cited by 4
Lee, C. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.01.005 · Cited by 3
Inhibitory Effect of Styrylpyrone Extract of Phellinus linteus on Hepatic Steatosis in HepG2 Cells
Chiu, C., Chen, M., Lieu, J.-J., Chen, C., Chang, C., Chyau, C.-C., & Peng, R. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043672 · Cited by 3
“The incidence and prevalence of nonalcoholic fatty liver disease (NAFLD) are rapidly rising worldwide [1,2].”
BackgroundChoorakuttil, R. M., Chaubal, R. N., Arunachalam, V. K., Bagri, N., Gupta, A., Bansal, J., Pratap, T., Sodani, V., & Nirmalan, P. K. (2022) · Indographics · doi:10.1055/s-0042-1759544 · Cited by 3
Bogomaz, V. M., Натрус, Л. В., Ziuz, N. Y., & Стародуб, Т. (2023) · International Journal of Health Governance · doi:10.1108/ijhg-09-2023-0087 · Cited by 3
Kostitska, I. O., Protas, N., & Petrovska, L. (2023) · Diabetes Obesity Metabolic Syndrome · doi:10.57105/2415-7252-2023-5-01 · Cited by 3
Ferretti, S. E., & Barreyro, F. J. (2024) · Current Hepatology Reports · doi:10.1007/s11901-023-00628-1 · Cited by 3
An, Z., Liu, Q., Ye, X., Zhang, Q., Pei, H.-F., Xin, X., Yuan, J., Huang, Q., Liu, K., Fang, L., et al. (2024) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000680 · Cited by 3
“The accurate and rapid diagnosis of MASLD and the hierarchical management of patients with MASLD are important (5).”
BackgroundSelf-citationTowards unifying fatty liver nomenclature: a voice from the Middle East and North Africa
Fouad, Y. M., Barakat, S., Hashim, A. H., & Ghazinyan, H. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00918-z · Cited by 3
“In our region as well as worldwide, NAFLD is not receiving proper attention from the health system community 2 .”
Self-citationKatsuyama, H., Horinaka, S., Hakoshima, M., Adachi, H., & Yanai, H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164929 · Cited by 3
“The global burden of MASLD is increasing at an alarming rate, with global prevalence reaching up to 32.4% [3,4].”
BackgroundInfluentialHepatocyte-Specific Yap1 Knockout Maintained the Liver Homeostasis of Lipid Metabolism in Mice
Li, C., Xue, Y., Liu, Y., Zheng, K., Gao, Y., Gong, Y., Lu, J., Zhang, Y., Ji, J., Zhang, Z., et al. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s472778 · Cited by 3
“22 Gypenosides (GP) can regulate the key genes involved in hepatic lipid metabolism in NAFLD mice, providing initial evidence for the mechanisms underlying the therapeutic effect of GP in NAFLD.”
BackgroundSelf-citationSystemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease
Rzeniewicz, K., & Sharma, R. (2024) · World Journal of Clinical Oncology · doi:10.5306/wjco.v15.i11.1394 · Cited by 3
Chrysavgis, L., & Cholongitas, Ε. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21938-2.00020-5 · Cited by 3
Non-alcoholic fatty liver disease: a global concern
Mortimore, G. (2022) · Practice Nursing · doi:10.12968/pnur.2022.33.9.358 · Cited by 3
The role of the gut microbiome in chronic liver diseases: Present insights and future outlook
Jiang, L., & Fan, J. (2023) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2023.09.003 · Cited by 3
Self-citationBobo, J. F. G., Keith, B. A., Marsden, J. E., Zhang, J., & Schreiner, A. D. (2024) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2024.07.028 · Cited by 2
Krishnan, A., & Mukherjee, D. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i3.105635 · Cited by 2
Tspo Depletion Exacerbates Steatosis Through Fatty Acid Uptake
Li, Y., Chen, L., Sottas, C. M., Patel, N. D., Raul, M. C., & Papadopoulos, V. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70500 · Cited by 3
Teng, F., Liu, H., Jiang, Y., Xu, S., Wang, X., Wang, X., Yang, Z.-Q., Li, M., Wang, R., Wang, Z., et al. (2025) · Phytotherapy Research · doi:10.1002/ptr.70049 · Cited by 2
Gündoğdu, A., Arıkan, M., Ulas, A., Koldaş, S. S., & Ece, G. T. (2025) · Next research. · doi:10.1016/j.nexres.2025.100846 · Cited by 3
Liver fibrosis is associated with clinical and economic burden of cardiovascular disease in MASH
Corey, K. E., Mehta, A., Mangla, K. K., Chandramouli, A. S., Shoeb, A., Krarup, N., Augusto, M., Grau, K., Varma, S., & Bugianesi, E. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101621 · Cited by 2
“3,4 10 In the coming decades, the burden of MASH to healthcare systems is predicted to greatly increase, as it is linked to the rising prevalence of obesity and type 2 diabetes (T2D) – both leading drivers of MASH.”
Self-citationCai, H.-J., Liang, H., Shi, L., Rong, Y.-H., Li, J., Zhang, Y., & Ma, R. (2025) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580251380071 · Cited by 2
“23,24”
Yang, R., Shen, C., Jia, Y., Yao, Y., Zhou, Y., Cheng, Y., Cheng, Y., Zeng, R., Wan, Z., Zhao, Q., et al. (2025) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000949 · Cited by 2
“It is a major driver of cirrhosis and hepatocellular carcinoma and accounts for most liver-related deaths (3,4), imposing a considerable health burden and substantial social and economic impacts (5,6).”
Zhang, R., Zhang, Q., Cui, Z., Huang, B., Li, M., & Ma, H. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02251-7 · Cited by 3
“The prevalence of NAFLD has been rising globally, posing a significant public health challenge due to its association with obesity, type 2 diabetes, and metabolic syndrome [3].”
The Liver at the Crossroads: Orchestrating Lipoprotein Dynamics and Lipid Homeostasis
Winterfeldt, K., & Siddiqi, S. A. (2026) · Livers · doi:10.3390/livers6010006 · Cited by 3
Zhu, G., Qu, Y., Chen, K., He, D., Wang, J., Tang, Z., Wang, X., Zhang, M., Jiang, P., Zhang, R., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341109 · Cited by 2
Hemati, H., Blanton, M. B., Rutt, L. N., Keiran, N., Geron, R. D., Lima, F., McCullough, R. L., & Messaoudi, I. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1783132 · Cited by 2
The C-reactive Protein–Triglyceride–Glucose Index in Relation to Liver Disease
Fang, J., & Liu, L. (2026) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580261433444 · Cited by 2
“A range of liver conditions, including viral hepatitis, 1 cirrhosis, 2 drug-induced liver injury, autoimmune liver diseases, alcohol-related liver disease, 3,4 and metabolic dys-function-driven non-alcoholic fatty liver disease (NAFLD), 5,6 collectively impose a substantial global health burden.”
Shao, G., Ye, C., Sun, C., Pan, J., Lu, L., Wang, L., Wu, T., Lin, Z., Ji, G., & Hanchen, X. U. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.04.018 · Cited by 2
Lin, J., Wu, T., Wang, C., Wei, Z., Liu, Y., Yang, G., Zhou, H., Luo, J., Fan, Z., Da, Y., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156623 · Cited by 3
Driessen, S., Broekman, L. D., de la Croix, A., der Vossen, M. M., Tushuizen, M. E., Maarsingh, O. R., & Holleboom, A. G. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.100991 · Cited by 2
“16,17 Recognizing this stepwise nature of knowledge transfer highlights the need for earlier, proactive primary care engagement in addressing emerging burdens like MASLD.”
Zheng, L., Zhou, J., Jin, H., Long, Y., Zheng, Y., Ding, K., Zheng, Z., Zhuge, F., Fu, Z., & Ni, Y. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70506 · Cited by 2
Conocimiento y abordaje de la esteatosis hepática metabólica entre endocrinólogos en España
Julián, M. T., Rubio, M. Á., Escalada, J., & Alonso, N. (2026) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2026.501846 · Cited by 2
A dual-microneedle system for integrated continuous glucose monitoring and feedback insulin delivery
Zhao, K., Niu, Y., Cao, X., Ma, T., & You, X. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127070 · Cited by 2
Anand, A. C., & Acharya, S. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.01.008 · Cited by 3
A novel nomogram based on GD for predicting prognosis in hepatocellular carcinoma
Liu, Y., Cui, K., Zhao, H., & Ma, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1174788 · Cited by 2
Willett, R. A., Tryndyak, V., Beland, F. A., & Pogribny, I. P. (2023) · Journal of Environmental Science and Health Part C · doi:10.1080/26896583.2023.2293493 · Cited by 2
Fuster‐Martínez, I., Català-Senent, J. F., Hidalgo, M. R., Roig, F. J., Esplugues, J. V., Apostolova, N., Garcia‐García, F., & Blas‐García, A. (2024) · The Journal of Pathology · doi:10.1002/path.6242 · Cited by 2
Metabolic dysfunction associated steatotic liver disease in resource-limited settings
Sonderup, M. W., Díaz, L. A., Arab, J. P., & Arrese, M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-87031-3.00029-9 · Cited by 2
Self-citationCharacteristics and survival of advanced untreated hepatocellular carcinoma of non-viral etiology
Ekanayaka, S. P. N., Luke, N. V., Thilakarathne, S., Dassanayake, A. S., Gunetilleke, M. B., Niriella, M. A., & Siriwardana, R. C. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-024-01636-9 · Cited by 2
Self-citationLuo, Q., Liu, G., Li, Q., Lu, J., Zheng, W., Huang, Y., & Li, C. (2024) · European Journal of Clinical Nutrition · doi:10.1038/s41430-024-01489-7 · Cited by 2
“Nonalcoholic fatty liver disease (NAFLD), which several associations have suggested renaming as metabolic-associated fatty liver disease (MAFLD), represents an expanding and underestimated global public health concern [1].”
Gazzar, W. B. E., Hannoun, L. M., Shaban, D. N., Rababa, F. M., Al-Maqableh, S. M., Zawahreh, H. B., Abujaber, A. A., Al-Sarhan, S. M., Bassiouni, J. A., & Nabil, N. (2024) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2024.101858 · Cited by 2
Karády, J., Mayrhofer, T., Foldyna, B., Lu, M. T., Meyersohn, N. M., Hoffmann, U., Balogon, O., Pagidipati, N. J., Shah, S. H., Douglas, P. S., et al. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18415 · Cited by 2
“Irreversible liver-related complications of HS are the most feared clinical outcomes in this patient population; however, the leading cause of morbidity and mortality among patients with HS is cardiovascular disease [5–8].”
Self-citationNonlinearity parameter imaging of local estimates using spatial compounding
Avilés, E., Lavarello, R., & Coila, A. (2024) · IEEE Ultrasonics, Ferroelectrics, and Frequency Control Joint Symposium (UFFC-JS) · doi:10.1109/uffc-js60046.2024.10793740 · Cited by 2
Kim, Y., Lee, T., & Oh, C. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03687-4 · Cited by 2
“Cardiovascular disease (CVD) is the leading cause of death in patients with SLD, reflecting the profound systemic effects of the disease [1, 4].”
Скрипник, І. М., Ohanisyan, E. V., Maslova, G. S., Непорада, К. С., Shaposhnyk, O. A., & Приходько, Н. П. (2025) · World of Medicine and Biology · doi:10.26724/2079-8334-2025-1-91-101-105 · Cited by 2
Shen, D., Song, S., Hu, J., Cai, X., Zhu, Q., Zhang, Y., Ma, R., Zhou, P., Zhang, Z., Hong, J., et al. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002986 · Cited by 3
Yan, J., Hou, Q., Liu, J., & Li, W. (2025) · Biomedical Chromatography · doi:10.1002/bmc.70156 · Cited by 2
Aldafermin in non-alcoholic steatohepatitis: a cautionary tale for trial design
Tsochatzis, E. A. (2022) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(22)00049-8 · Cited by 2
Self-citationGut Microbiota, NAFLD and COVID-19: A Possible Interaction
Finelli, C. (2022) · Obesities · doi:10.3390/obesities2020017 · Cited by 2
“NAFLD/NASH will undoubtedly overlap with COVID-19 due to the enormous global prevalence of NAFLD and NASH, which affect around 25% of the global population [22].”
BackgroundAlias, M. A., Rahim, R. A., Muhammad, S. A. N., Abdullah, N. Z., Talib, N. A., & Affandi, K. A. (2022) · IIUM Medical Journal Malaysia · doi:10.31436/imjm.v21i4.2107 · Cited by 4
Wang, Q., Feng, Y., & Hu, A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1152809 · Cited by 2
Identification and Validation of Hub Immune-Related Genes in Non-Alcoholic Fatty Liver Disease
Li, J., Kou, C., Sun, T., Liu, J., & Zhang, H. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s413545 · Cited by 2
Bangaru, S. D., Sundaresh, R., Lee, A. H., Prause, N., Hao, F., Dong, T. S., Tincopa, M. A., Cholankeril, G. T., Rich, N. E., Kawamoto, J. K., et al. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08043-8 · Cited by 2
“…for early identification [32, 44], we propose that incorporating our predictive algorithm in VHA EHR would simplify the identification of at-risk Veterans in primary care and endocrinology clinics, who can subsequently be risk stratified for advanced fibrosis by non-invasive tests [11, 44, 45].”
MethodZhao, J., & Liu, L. (2026) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2025.0157 · Cited by 2
Jin, L., Cui, Y., Zhang, Q., Xiong, Y., Zheng, X., Ye, J., Zhang, A., Xiao, Z., Zhuang, Z., Liang, G., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114053 · Cited by 1
Metadata
- Authors
- Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., Francque, S., George, J., Hagström, H., Huang, T. T.-K., Ismail, M. H., Kautz, A., Sarin, S. K., Loomba, R., Miller, V., Newsome, P. N., Ninburg, M., Ocama, P., Ratziu, V., Rinella, M., Romero, D., Romero-Gómez, M., Schattenberg, J. M., Tsochatzis, E. A., Valenti, L., Wong, V. W.-S., Yilmaz, Y., Younossi, Z. M., Zelber-Sagi, S., the NAFLD Consensus Consortium, Åberg, F., Adams, L., Khatry, M. S. A., Naamani, K. A., Murillo, O. A., Allen, A. M., Alnaser, F., Alqahtani, S. A., Alswat, K., Alvaro, D., Andrade, R. J., Arrese, M., Awuku, Y. A., Ayesha, M., Baatarkhuu, O., Bakieva, S., Basu, R., Bataller, R., Bedri, S., Bosi, E., Bourliere, M., Bruha, R., Bugianesi, E., Burra, P., Buti, M., Byrne, C. D., Calleja, J. L., Carrieri, P., Carter, F., Fernandez, M. I. C., Castillo-Lopez, G., Castro-Narro, G. E., Chan, H. L. Y., Chan, W.-K., Chang, Y., Colombo, M., Coppell, K. J., Corey, K., Craxi, A., Cryer, D., Dassanayake, A., Martins, A. D. A. S., de Ledinghen, V., DelPrato, S., Demaio, A., Desalegn, H., Dillon, J., Duseja, A., Dorairaj, P., Ekstedt, M., El Kassas, M., Elsanousi, O. M., Esmat, G., Fan, J.-G., Farpour-Lambert, N., Flisiak, R., Fouad, Y., Fuchs, M., Gani, R. A., Gerber, L., Ghazinyan, H., Gheorghe, L., Goh, G. B.-B., Grønbæk, H., Gulnara, A., Hamid, S., Hebditch, V., Hickman, I. J., Hocking, S. L., Hunyady, B., Idilman, R., Isakov, V. A., Jamal, M. H., Jepsen, P., Iskandar, N. J., Song, M. J., Sudhamshu, K. C., Kakizaki, S., Kalamitsis, G., Kanwal, F., Kao, J.-H., Kaplan, L., Kawaguchi, T., Khader, Y., Kim, S. U., Kodjoh, N., Koek, G., Koike, K., Komas, N. P., Korenjak, M., Kugelmas, M., Labidi, A., Lange, N. F., Lavine, J. E., Lazo, M., Lee, N., Lesmana, C. R. A., Liu, C.-J., Long, M. T., Lopez-Jaramillo, P., Malekzadeh, R., Mahtab, M. A., Marchesini, G., Marinho, R., Vázquez, S. E. M., Mateva, L., Nlombi, C. M., Melin, P., Mikolasevic, I., Milovanovic, T., Musso, C., Nakajima, A., Nava, E., Nersesov, A. V., Nikolova, D., Norris, S., Novak, K., Oben, J., Ong, J. P., Onyekwere, C., Papatheodoridis, G., Paruk, I., Patel, K., Macedo, M. P., Penha-Gonçalves, C., Figueroa, M. P., Hofmann, W. P., Petta, S., de Oliveira, C. P. M. S., Puri, P., Pan, C. Q., Rac, M., Ralston, J., Ramji, A., Razavi, H., Alvares-da-Silva, M. R., Roberts, S., Roden, M., Rose, T., Rouabhia, S., Rovere-Querini, P., Rowe, I. A., Sadirova, S., Salupere, R., Saparbu, T., Sayegh, R., Sebastiani, G., Seki, Y., Selmo, J., Serme, A. K., Shaw, J. E., Shenoy, T., Sheron, N., Shibolet, O., Silva, M., Skrypnyk, I., Socha, P., Soriano, J., Spearman, C. W., Sridharan, K., Suárez, J. J., Sheriff, D. S., Sung, K.-C., Swain, M., Tacke, F., Taheri, S., Tan, S.-S., Tapper, E. B., Yki-Järvinen, H., Thiele, M., Shawa, I. T., Tolmane, I., Torres, E. A., Trauner, M., Treeprasertsuk, S., Turcanu, A., Valantinas, J., Vesterhus, M., Waked, I., Wild, S. H., Willemse, J., Wong, R. J., Xanthakos, S., Young, D. Y., Yu, M.-L., Zheng, K. I., Zeybel, M., & Zheng, M.-H.
- Affiliations
- Barcelona Institute for Global Health (ES)
- European Association for the Study of the Liver (CH)
- NIHR Newcastle Biomedical Research Centre (GB)
- Pontificia Universidad Católica de Chile (CL)
- University College London Hospitals NHS Foundation Trust (GB)
- Marqués de Valdecilla University Hospital (ES)
- Veterans Health Administration (US)
- University of Washington (US)
- University of Antwerp (BE)
- The University of Sydney (AU)
- Karolinska Institutet (SE)
- City University of New York (US)
- King Fahd Hospital of the University (SA)
- Institute of Liver and Biliary Sciences (IN)
- University of California San Diego (US)
- University of California, Berkeley (US)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Makerere University (UG)
- Université Paris Cité (FR)
- Northwestern University (US)
- The Graduate Center, CUNY (US)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- The Royal Free Hospital (GB)
- University of Milan (IT)
- Chinese University of Hong Kong (HK)
- Marmara University (TR)
- Inova Health System (US)
- University of Helsinki (FI)
- The University of Western Australia (AU)
- Mayo Clinic (US)
- Johns Hopkins University (US)
- King Saud University (SA)
- Sapienza University of Rome (IT)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- University of Health and Allied Sciences (GH)
- University of KwaZulu-Natal (ZA)
- Mongolian National University of Medical Sciences (MN)
- Ministry of Health of the Republic of Uzbekistan (UZ)
- University of Virginia (US)
- University of Pittsburgh (US)
- Ahfad University for Women (SD)
- Vita-Salute San Raffaele University (IT)
- University of Turin (IT)
- University of Padua (IT)
- University of Southampton (GB)
- Inserm (FR)
- University of the West Indies (BS)
- Universidad de Buenos Aires (AR)
- Union Hospital (HK)
- University of Malaya (MY)
- Kangbuk Samsung Hospital (KR)
- IRCCS Ospedale San Raffaele (IT)
- University of Otago (NZ)
- Harvard University (US)
- University of Kelaniya (LK)
- University of Pisa (IT)
- St. Paul's Hospital Millennium Medical College (ET)
- University of Dundee (GB)
- Post Graduate Institute of Medical Education and Research (IN)
- World Heart Federation (CH)
- Linköping University (SE)
- National Ribat University (SD)
- Cairo University hospitals (EG)
- Shanghai Jiao Tong University (CN)
- Medical University of Białystok (PL)
- Minia University (EG)
- Virginia Commonwealth University (US)
- University of Indonesia (ID)
- Carol Davila University of Medicine and Pharmacy (RO)
- Singapore General Hospital (SG)
- Aarhus University Hospital (DK)
- Aga Khan University (PK)
- British Liver Trust (GB)
- Princess Alexandra Hospital (AU)
- Kuwait University (KW)
- Hlabisa Hospital (ZA)
- Catholic University of Korea (KR)
- National Academy of Medical Sciences (NP)
- National Hospital Organization Takasaki General Medical Center (JP)
- Baylor College of Medicine (US)
- National Taiwan University Hospital (TW)
- Kurume University (JP)
- Jordan University of Science and Technology (JO)
- Yonsei University (KR)
- Université d'Abomey-Calavi (BJ)
- Maastricht University Medical Centre (NL)
- The University of Tokyo (JP)
- Institut Pasteur de Bangui (CF)
- Denver Public Library (US)
- Hôpital La Rabta (TN)
- University Hospital of Bern (CH)
- Columbia University (US)
- Drexel University (US)
- Wilton Park (GB)
- Boston University (US)
- University of Tehran (IR)
- Bangladesh Medical University (BD)
- University of Bologna (IT)
- Centro Hospitalar Lisboa Norte (PT)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- University Hospital St. Ivan Rilski (BG)
- University of Kinshasa (CD)
- Favaloro Foundation (AR)
- Yokohama City University (JP)
- Universidad Autónoma de Nuevo León (MX)
- Ss. Cyril and Methodius University in Skopje (MK)
- St. James's Hospital (IE)
- Ljubljana University Medical Centre (SI)
- Guy's Hospital (GB)
- University of the Philippines Manila (PH)
- Lagos State University (NG)
- National and Kapodistrian University of Athens (GR)
- University Health Network (CA)
- Universidade Nova de Lisboa (PT)
- University of Palermo (IT)
- NYU Langone Health (US)
- World Obesity Federation (GB)
- University of British Columbia (CA)
- Center for Disease Analysis (US)
- Alfred Health (AU)
- Düsseldorf University Hospital (DE)
- University of Leeds (GB)
- Tartu University Hospital (EE)
- Kyrgyz State Medical Academy (KG)
- Saint Joseph University (LB)
- McGill University Health Centre (CA)
- Yotsuya Medical Cube (JP)
- Baker Heart and Diabetes Institute (AU)
- King's College London (GB)
- Tel Aviv University (IL)
- Children's Memorial Health Institute (PL)
- Hospital Universitario de La Princesa (ES)
- University of Cape Town (ZA)
- Arabian Gulf University (BH)
- Universidad San Francisco de Quito (EC)
- University of Calgary (CA)
- Charité – Universitätsmedizin Berlin (DE)
- Weill Cornell Medical College in Qatar (QA)
- Hospital Selayang (MY)
- University of Michigan (US)
- University of Southern Denmark (DK)
- University of Malawi (MW)
- Riga East University Hospital (LV)
- University of Puerto Rico, Medical Sciences Campus (PR)
- Medical University of Vienna (AT)
- Chulalongkorn University (TH)
- Nicolae Testemițanu State University of Medicine and Pharmacy (MD)
- Vilnius University Hospital Santariskiu Klinikos (LT)
- Haraldsplass Diakonale Sykehus (NO)
- National Liver Institute (EG)
- University of Edinburgh (GB)
- Stanford Medicine (US)
- Cincinnati Children's Hospital Medical Center (US)
- National University of Singapore (SG)
- Kaohsiung Medical University (TW)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Koç University (TR)
- Corresponding author
- Lazarus, Jeffrey V.
- ORCID
- Lazarus, Jeffrey V.
- Mark, Henry E.
- Anstee, Quentin M.
- Arab, Juan Pablo
- Batterham, Rachel L.
- Castera, Laurent
- Cortez-Pinto, Helena
- Crespo, Javier
- Cusi, Kenneth
- Dirac, M. Ashworth
- Francque, Sven
- George, Jacob
- Hagström, Hannes
- Huang, Terry T.-K.
- Ismail, Mona H.
- Sarin, Shiv Kumar
- Loomba, Rohit
- Miller, Veronica
- Newsome, Philip N.
- Ninburg, Michael
- Ocama, Ponsiano
- Ratziu, Vlad
- Rinella, Mary
- Romero, Diana
- Romero-Gómez, Manuel
- Schattenberg, Jörn M.
- Tsochatzis, Emmanuel A.
- Valenti, Luca
- Wong, Vincent Wai-Sun
- Yilmaz, Yusuf
- Younossi, Zobair M.
- Åberg, Fredrik
- Adams, Leon
- Naamani, Khalid Al
- Allen, Alina M.
- Alqahtani, Saleh A.
- Alswat, Khalid
- Alvaro, Domenico
- Andrade, Raúl J.
- Arrese, Marco
- Awuku, Yaw Asante
- Baatarkhuu, Oidov
- Bakieva, Shokhista
- Basu, Rita
- Bataller, Ramon
- Bedri, Shahinaz
- Bosi, Emanuele
- Bugianesi, Elisabetta
- Burra, Patrizia
- Byrne, Christopher D.
- Carrieri, Patrizia
- Chan, Henry Lik Yuen
- Chan, Wah-Kheong
- Chang, Yoosoo
- Colombo, Massimo
- Coppell, Kirsten J.
- Corey, Kathleen
- Cryer, Donna
- Dassanayake, Anuradha
- Desalegn, Hailemichael
- Dillon, John
- Duseja, Ajay
- Ekstedt, Mattias
- Elsanousi, Osama M.
- Esmat, Gamal
- Fan, Jian-Gao
- Flisiak, Robert
- Fouad, Yasser
- Fuchs, Michael
- Gani, Rino A.
- Gerber, Lynn
- Gheorghe, Liana
- Goh, George Boon-Bee
- Grønbæk, Henning
- Hamid, Saeed
- Hickman, Ingrid J.
- Hocking, Samantha L.
- Jamal, Mohammad H.
- Jepsen, Peter
- Song, Myeong Jun
- Kakizaki, Satoru
- Kanwal, Fasiha
- Kao, Jia-Horng
- Kaplan, Lee
- Kawaguchi, Takumi
- Khader, Yousef
- Kim, Seung Up
- Kodjoh, Nicolas
- Koek, Ger
- Koike, Kazuhiko
- Komas, Narcisse Patrice
- Korenjak, Marko
- Kugelmas, Marcelo
- Labidi, Asma
- Lange, Naomi F.
- Lavine, Joel E.
- Lazo, Mariana
- Lee, Nancy
- Lesmana, Cosmas Rinaldi A.
- Liu, Chun-Jen
- Long, Michelle T.
- Malekzadeh, Reza
- Mahtab, Mamun Al
- Marchesini, Giulio
- Marinho, Rui
- Vázquez, Sophia E. Martínez
- Nlombi, Charles Mbendi
- Musso, Carla
- Nakajima, Atsushi
- Norris, Suzanne
- Oben, Jude
- Ong, Janus P.
- Onyekwere, Charles
- Papatheodoridis, George
- Paruk, Imran
- Patel, Keyur
- Macedo, M. Paula
- Figueroa, Marlene Pérez
- Hofmann, Wolf Peter
- Petta, Salvatore
- Puri, Puneet
- Pan, Calvin Q.
- Ralston, Johanna
- Ramji, Alnoor
- Razavi, Homie
- Roberts, Stuart
- Roden, Michael
- Rowe, Ian A.
- Sadirova, Shakhlo
- Sebastiani, Giada
- Seki, Yosuke
- Shaw, Jonathan E.
- Sheron, Nick
- Shibolet, Oren
- Silva, Marcelo
- Socha, Piotr
- Soriano, Joan
- Spearman, C. Wendy
- Sridharan, Kannan
- Sheriff, Dhastagir Sultan
- Sung, Ki-Chul
- Swain, Mark
- Tacke, Frank
- Taheri, Shahrad
- Tan, Soek-Siam
- Tapper, Elliot B.
- Thiele, Maja
- Shawa, Isaac Thom
- Tolmane, Ieva
- Torres, Esther A.
- Trauner, Michael
- Treeprasertsuk, Sombat
- Turcanu, Adela
- Valantinas, Jonas
- Vesterhus, Mette
- Waked, Imam
- Wild, Sarah H.
- Wong, Robert J.
- Xanthakos, Stavra
- Yu, Ming-Lung
- Zheng, Kenneth I.
- Zheng, Ming-Hua
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2021-10-27
- Volume
- 19
- Issue
- 1
- Pages
- 60-78
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W3208129759
- Cited by
- 757
- References
- 193
- Citations by year
- 2026: 100 · 2025: 156 · 2024: 163 · 2023: 201 · 2022: 127 · 2021: 9
- FWCI
- 19.36
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Dspace Repository (Marmara Üniversitesi) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Falk Foundation
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Celgene
- City University of New York
- Medpace
- Regeneron Pharmaceuticals
- European Federation of Pharmaceutical Industries and Associations
- Arrowhead Pharmaceuticals
- Medicines Company
- Galecto
- Intercept Pharmaceuticals
- NGM Biopharmaceuticals
- Coherus Biosciences
- National Institute for Health and Care Research (RP-2015-06-005)
- Rosetrees Trust
- Novo Nordisk
- Astellas Pharma
- Shionogi
- European Association for the Study of the Liver
- Novo Nordisk Fonden (NNF18OC0054612)
- Servier
- Julius Clinical
- Genentech
- Allergan
- Novartis Pharma
- Takeda Pharmaceuticals International
- Sanofi-Aventis Deutschland
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, public health policy, global health agenda, metabolic syndrome, non-communicable diseases, obesity, health system response, Delphi consensus
- MeSH terms
- Humans, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.